Surprising new FDA remarks to AABB on cord biologics misuse & stem cell clinics
The Association for the Advancement of Blood & Biotherapies or AABB recently had a very useful Q&A with the FDA on cord blood use. There are some important new things from the FDA on the marketing and use of cord blood in there. The agency was also quite blunt in some ways about the challenges, […]
Surprising new FDA remarks to AABB on cord biologics misuse & stem cell clinics Read More »